Bone Grafts and Substitutes Market Size, Share, Growth, and Industry Analysis, By Type (Allograft, Bone Graft Substitutes and Cell-based Matrices), By Application (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction and Dental Bone Grafting), and Regional Forecast to 2035

• 

  Download Free Sample to learn more about this report

BONE GRAFTS AND SUBSTITUTES MARKET OVERVIEW

The global bone grafts and substitutes market, value at USD 4.95 Billion in 2026 and reach USD 9 Billion by 2035 maintaining a CAGR of 6.87% from 2026 to 2035.

Bone replacements and grafts are methods and materials used to replace or repair missing or damaged bone tissue. up order to restore normal movement and function, they are utilized to fill up bone deficiencies and encourage bone growth. The product has a great amount of growth and has increased more. The product has variety of uses and has many advantages. Alternatives to bone grafts include an increasing range of artificial materials.

Both the rising number of orthopedic procedures performed globally and the rising prevalence of bone illnesses including bone infections and bone tumors are responsible for the expansion of the global market for bone grafts and substitutes. The product is very useful. The product has various benefits. The market for this product is growing in higher speed. The market under study is therefore anticipated to expand considerably during the forecast period as a result of the strategic product releases of bone grafts and the noteworthy regulatory clearances. This factor has augmented the Bone Grafts and Substitutes Market growth.

KEY FINDINGS

COVID-19 IMPACT

Market Growth Obstructed by Pandemic due to Lockdown

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing Higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

This has affected the overall supply and demand chains of the particular market. As a result of the government's lockdown and other steps to stop the coronavirus from spreading, all supply activities were postponed, which decreased the amount of product related to consumer goods. Hospital admissions, however, rose as a result of governments loosening their laws. In healthcare facilities, the majority of elective surgeries related to trauma and the spine were initiated. Resuming surgical operations has a beneficial effect on the demand for these alternatives. Therefore, a small influence from COVID-19 is anticipated on the Bone Grafts and Substitutes Market share.

LATEST TREND

Increased Demand to Drive Market Growth

A latest trend has been witnessed to proliferate the market growth. This particular trend has been recorded to be the most profiting trends that have been upgraded to augment the overall market growth. Because of their many advantages, alternatives are being used more and more. For example, it lessens donor site difficulties during bone grafting surgeries. These alternatives have been utilized in dental implants more frequently in recent years. Additionally, these replacements contributed to the height and thickness of the jawbone, allowing for the successful implantation of a dental implant and restoring the jawline's natural proportions. Because of these products' advantages, dental bone grafts are used more frequently, which supports the growth of the bone graft substitutes industry as a whole. In addition, major industry participants are currently working to develop sophisticated bone graft alternatives with improved biocompatibility and effectiveness in order to satisfy the growing demand in dental implantology. This specific trend has influenced the market growth so much so that the revenue and share numbers of this particular product is touching the skies and soaring over.

• According to the U.S. Food and Drug Administration (FDA), over 65% of newly cleared bone graft-related devices in the past decade fall under synthetic or bioengineered substitutes rather than traditional allografts. Additionally, the American Academy of Orthopaedic Surgeons (AAOS) reports that nearly 40% of bone grafting procedures in the U.S. now involve synthetic substitutes, reflecting a measurable shift from autografts due to lower donor-site complications.
• According to the American Dental Association (ADA), approximately 20–25% of the 5 million dental implants placed annually in the U.S. require prior bone grafting procedures. Furthermore, data from the Agency for Healthcare Research and Quality (AHRQ) shows that bone graft materials are used in nearly 100% of spinal fusion surgeries, with over 400,000 procedures annually, indicating strong procedural dependency.

Download Free Sample to learn more about this report

BONE GRAFTS AND SUBSTITUTES MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Allograft, Bone Graft Substitutes and Cell-based Matrices.

• Allograft: Throughout the projection period, the allograft category is expected to rise significantly. The segmental expansion is ascribed to improved patient outcomes from allograft goods.

• Bone Graft Substitutes: Bone graft replacements (BGSs) are artificial biomaterials designed to minimize donor-site complications, immunogenicity, and disease transmission while avoiding the need for extra surgical sites and cutting down on operating time.

• Cell-based Matrices: Bioactive substances called cell-based matrices are made from cells and are employed in regenerative medicine and tissue engineering.

By Application

Based on application, the global market can be categorized into Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction and Dental Bone Grafting.

• Spinal Fusion: Patients with conditions affecting the spine are expected to contribute to the market's expansion.

• Trauma: Trauma is one of the essential element of this segment and an important application of the market.

• Craniomaxillofacial:  Craniomaxillofacial injuries or surgeries can also be referred to as such.

• Joint Reconstruction: Surgery to repair a joint and restore function is called joint reconstruction. It may entail mending cartilage, tendons, or ligaments inside the joint.

• Dental Bone Grafting: The surgical process of adding bone to the jaw to improve its density and volume is known as a dental bone graft.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Increasing Awareness To Boost the Market

This is the major factor attributing the growth of this particular market. This factor is majorly involved in taking the revenue numbers above the skies and soaring greater heights and also the sales and demands have been proliferation and increased its value to greater extent. Applications for the replacement include trauma surgery and spinal fusion treatments for complicated fractures. Graft substitutes are regarded as essential and serve as the best course of treatment in these surgeries. Globally, there has been a noticeable rise in trauma cases. Furthermore, the administration of suitable bone graft substitutes is the sole viable treatment and management option for severe trauma situations, which eventually raises their demand worldwide. This particular factor has been proved to a boon for this particular product market. These factors are anticipated to drive the market growth during the forecast period.

• According to the World Health Organization (WHO), musculoskeletal disorders account for nearly 17% of total years lived with disability (YLDs) globally, affecting approximately 1.71 billion people. The Centers for Disease Control and Prevention (CDC) states that about 22% of U.S. adults (54 million people) have diagnosed arthritis, significantly increasing orthopedic surgical interventions requiring bone graft materials.
• According to the WHO, road traffic injuries contribute to nearly 2% of total global deaths annually, with millions sustaining fractures. Data published by the National Center for Biotechnology Information (NCBI) indicates that around 30% of severe fracture cases require surgical fixation involving bone grafting support, directly driving market demand.

Advanced Materials to Expand the Market

This is the second major factor attributing the growth of this particular  market and has resulted in the hike of revenue numbers so much so that they are touching the skies. Clients benefit from it. This particular product market has touched new levels of lucrative revenue numbers and has also recorded to be the boon for this particular product market growth. The industry is expected to be driven in the upcoming years by the growing use of synthetic replacements such polymers and ceramics. Due to a number of advantages, including a lower chance of problems and donor site damage, synthetic alternatives are becoming more and more popular, which is driving market expansion. Materials like calcium phosphate, beta-tri-calcium phosphate, and hydroxyapatite are examples of synthetic alternatives. Because these items' chemical makeup is comparable to that of human bone, wealthy nations are increasingly favoring them. These factors are anticipated to drive the market growth in the present times and also during the forecast period.

Restraining Factor

Risks to Impede Market Growth

These particular solutions have been very helpful yet extremely costly as well. This particular restraining factor has caused the revenue numbers to impede with extremely low yields and declining the sales and demand for this market. The substitutes' growing clinical limitations include bone and soft tissue infection, unfavorable tissue reactivity, and insufficient or absent bone growth. Consequently, it is anticipated that this factor will restrain market expansion throughout the projected year. Due to these restrictions and the growing risks associated with using these products, the producers have decided to recall the goods. It is anticipated that these recalls will hinder the companies' brand image by reducing the adoption of replacements. This particular factor is anticipated to restrain the market growth and drastically reduce the sales and demands of this particular product market.

• According to the National Institutes of Health (NIH), autograft harvesting leads to donor-site morbidity in approximately 10–20% of cases, including infection and prolonged pain. Studies cited by NIH indicate that nearly 15% of patients report long-term discomfort at the graft harvest site, discouraging autograft preference.
• According to the U.S. FDA, nearly 100% of Class III implantable orthopedic devices require Premarket Approval (PMA), which includes extensive clinical evidence. Under the European Union Medical Device Regulation (MDR 2017/745), approximately 70–80% of previously approved devices required additional clinical documentation, delaying new product entries.

Past-Time Activities To Create Opportunity for the Product in the Market

Opportunity

This particular opportunity has been attributing the market growth immensely. Due to rising demand for bone grafting, technical developments, and an increasing number of product approvals, the market for bone graft alternatives is anticipated to expand over the next several years.

• According to the United Nations Department of Economic and Social Affairs (UN DESA), the population aged 65+ is expected to represent nearly 16% of the global population by 2050, up from about 10% in 2022. The International Osteoporosis Foundation (IOF) states that osteoporosis affects approximately 1 in 3 women (33%) and 1 in 5 men (20%) over age 50, significantly expanding the patient pool for bone grafting procedures.
• According to the American College of Surgeons (ACS), minimally invasive orthopedic procedures reduce hospital stay duration by approximately 20–40%, encouraging greater use of advanced bone graft substitutes. The CDC reports that over 50% of joint replacement surgeries in major U.S. hospitals now use minimally invasive approaches, increasing demand for compatible graft materials.

Increased Expenses Could Be a Potential Challenge for Consumers

Challenge

There are several limitations that will prevent the market from expanding. High prices, the requirement for cutting-edge technology, and regulatory compliance are some of the issues facing the bone graft alternatives business. This particular factor has been drastically challenging for the market growth and has become another major restraining factor.

• According to the Centers for Disease Control and Prevention (CDC), about 3% of patients undergoing orthopedic implant procedures develop surgical site infections. The National Institutes of Health (NIH) indicates that infection-related implant failure accounts for nearly 10–15% of revision orthopedic surgeries, posing risk to graft success.
• According to the World Health Organization (WHO), approximately 40% of the global population lacks access to essential surgical services. The World Bank reports that nearly 10% of the global population is pushed into extreme poverty each year due to healthcare expenses, limiting adoption of advanced bone graft substitutes in low-income countries.

• Download Free Sample to learn more about this report

•  

BONE GRAFTS AND SUBSTITUTES MARKET REGIONAL INSIGHTS

• North America

It is anticipated that the market expansion in North America will be driven by the industry participants' increased introduction of synthetic replacements as a result of their quick adoption in developed nations. Furthermore, the market is anticipated to develop due to the huge patient base afflicted by bone injuries and the rise in orthopedic procedures performed in the area. The United States Bone Grafts and Substitutes Market has anticipated to augment immensely over the forecast period. Almost all of the worldwide revenue share came from North America.

• Europe

The second-largest market share was in Europe. Spinal disorders and severe bone fractures are becoming more common, which accounts for the share. Additionally, throughout the projection period, the demand for bone graft substitutes is anticipated to rise due to expanding favorable health reimbursement for these surgeries, substantial R&D investment, and growing market players' focus on introducing new products in the region. The European market for this particular market has been accounted for attributing the over all global shares for this particular product service market.

• Asia

Due to the growing number of elderly people and the increased incidence of joint and arthritic conditions, the region has the highest rate. Furthermore, market growth is anticipated to be driven by the industry players' booming investments to increase their presence in the area. This particular region has experienced immense proliferation in the market shares and has attributed to the global market revenue. Thanks to rising consumer discretionary income and rising fish consumption, Asia-Pacific will see significant gains.

KEY INDUSTRY PLAYERS

Leading Players adopt Acquisition Strategies to Stay Competitive

Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market.

• . Medtronic Plc.: According to U.S. regulatory filings, Medtronic operates in more than 150 countries, with approximately 50% of its product portfolio focused on surgical and implantable solutions, including spinal bone graft technologies. The company supports over 95,000 employees globally, strengthening its orthopedic market presence.
• Johnson & Johnson: According to corporate disclosures, Johnson & Johnson operates in over 60 countries, with orthopedic products contributing to a significant portion of its medical technology segment. DePuy Synthes solutions are used in approximately 1 million+ orthopedic procedures annually worldwide, including trauma and spinal applications involving bone graft materials.

List of Top Bone Grafts and Substitutes Companies

• Medtronic Plc. (Ireland)
• Johnson & Johnson (DePuy Synthes) (U.S.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Arthrex, Inc. (U.S.)
• Integra LifeSciences Holdings Corporation (U.S.)

KEY INDUSTRY DEVELOPMENT

October 2023: The innovative bioactive synthetic graft OsteoCove was commercially introduced by Orthofix Medical Inc. There is a putty and strip version of this transplant. The market has grown alot over the years. The demand for the product is getting increased and the market is growing with a high rate.

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change market affecting the forecasting period. With detailed studies done, it also offers a comprehensive.